George A. Fisher Jr.
Clinical Trials
- An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome Recruiting
- Clinical and Pathologic Studies of Patients Undergoing Treatment with EGFR Inhibitors Recruiting
- Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma Recruiting
- Phase II Capecitabine, Oxaliplatin & Bevacizumab for Metastatic / Unresectable Neuroendocrine Tumors Recruiting
- Phase III, Open-Label Study of Nilotinib Versus Imatinib in GIST Patients Recruiting
- A Phase 1/2 Study of Aflibercept Administered in Combination with Pemetrexed and Cisplatin in Patients with Advanced Carcinoma Recruiting
- A Phase II Study of GSK1363089 (Formerly XL880) for Metastatic Gastric Cancer Recruiting
- A Study of ASA404 or Placebo in Combination With Docetaxel in Second-Line Treatment for (Stage IIIb/IV) Non-Small Cell Lung Cancer (ATTRACT-2) Recruiting
- A Study of XL184 With or Without Erlotinib in Adults With Non-Small Cell Lung Cancer Recruiting
- An Observational Study of the Ethnic Impact of Patients Undergoing 2nd Line Treatment for Non-Small Cell Lung Cancer Using Pemetrexed Recruiting
- Assessment of Health Related Quality of Life in Patients Treated for Rectal Cancer Recruiting
- Avastin/[18-F]-5-fluorouracil PET/CT Imaging Feasibility Project Recruiting
- Molecular Genetic and Pathological Studies of Anal Tumors Recruiting
- Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy Recruiting
- PII Combination SBRT with TACE for Unresectable Hepatocellular Carcinoma Recruiting
- Permission to Collect Blood over Time for Research Recruiting
- Ph I Dose-Escalation of AEG40826-2HCI for Advanced Solid Tumors Recruiting
- Ph III Randomized Study of Four Weeks of High-Dose IFN-á2b for Microscopic Melanoma Recruiting
- Phase 1 Trial of Oral Ixabepilone Recruiting
- Phase I Vandetanib plus Capecitabine, Oxaliplatin and Bevacizumab for Metastatic Colorectal Cancer Recruiting
- Study of XL518 in Adults With Solid Tumors Recruiting
- Phase I/II Intratumoral DC Immunotherapy With Gemcitabine & XRT in Unresectable Pancreatic Cancer Completed
- Phase I/II PTK787/ZK 222584 and Gemcitabine in Advanced Pancreatic Cancer No longer recruiting
- Safety Study of Cetuximab in combination with Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-advanced Rectal Cancer Completed
- A Phase I/II Study of HKI-272 in Combination With Paclitaxel in Subjects With Advanced Solid Tumors and Breast Cancer No longer recruiting
- Cyberknife Radiosurgery for Locally Advanced Pancreatic Cancer Completed
- Evaluation of Stereotactic Radiosurgery For Liver Malignancies Completed
- Investigate Role of Metabolic Imaging in Predicting Tumor Response/Outcome After Pancreatic CA Tx Completed
- Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer Suspended
- Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancer No longer recruiting
- Study of XL647 Administered Orally Daily to Patients With Solid Tumors No longer recruiting
- Study of XL647 in Subjects With NSCLC Who Have Progressed After Responding to Treatment With Gefitinib or Erlotinib No longer recruiting
- Trilogy Stereotactic Body Radiotherapy for Pancreatic Cancer Completed
Help
Trial Administration